How has fentanyl use changed and why it matters?

A shift in drug use patterns and its public‑health effects

After decades of rising overdose deaths, recent reporting and analysis point to a notable change in how people are consuming fentanyl in parts of the United States: injection is declining while smoking the drug has become more common. Observers link this shift to an overall fall in drug‑related deaths in recent years, reversing a long upward trend.

Why the change may reduce fatalities

Researchers and public‑health experts suggest several mechanisms that could explain why fewer people are dying even as fentanyl remains widespread:

• Smoking delivers the drug differently than injection, potentially altering overdose risk and timing.
• Reduced injection lowers transmission risks for bloodborne infections and avoids some harms tied to syringe use.
• Changes in the drug supply and the emergence of different synthetic opioids have altered patterns of use and risk in complex ways.

What public‑health officials worry about

• Highly potent synthetic opioids such as nitazenes remain a serious threat because they can be many times more powerful than fentanyl; these drugs are implicated in inquests and fatality reports.
• It’s still unclear how durable the recent decline in deaths will be and how much it is driven by changes in use versus harm‑reduction efforts, shifts in supply, or enhanced access to naloxone and treatment.

Implications for policy and services

Public‑health responses should adapt to evolving patterns: expand harm‑reduction services tuned to noninjecting use, maintain widespread naloxone access, monitor emerging synthetic opioids, and invest in surveillance that captures changing consumption behaviors. Continued study is needed to untangle cause and effect and to guide tailored interventions.